Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end ...

Under the terms of the J&J deal, Isomorphic will be responsible for in silico predictions and design, while the US group will ...

(Bloomberg) -- Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive ...

Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment. It ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

The company will build off of breakthroughs in protein prediction from DeepMind and inches Big Tech one step further into the healthcare industry. Reading time 2 minutes Alphabet has spun off a new ...

AI-powered drug company spun out of Google’s DeepMind says human trials are ‘very close’ Alphabet’s AI drug discovery arm could soon begin testing its cancer medicines in humans. DeepMind’s new ...

Originally hailing from Troy, Ohio, Ry Crist is a writer, a text-based adventure connoisseur, a lover of terrible movies and an enthusiastic yet mediocre cook. A CNET editor from 2013 to 2024, Ry's ...

Google DeepMind and Isomorphic Labs have released AlphaFold 3, an advanced AI model designed to predict the structure and interactions of biological molecules, including proteins, DNA, RNA, and ...

Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end ...